The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System

An important manifestation of severe COVID-19 is the ARDS-like lung injury that is associated with vascular endothelialitis, thrombosis, and angiogenesis. The intravascular innate immune system (IIIS), including the complement, contact, coagulation, and fibrinolysis systems, which is crucial for rec...

Full description

Bibliographic Details
Main Authors: Miklós Lipcsey, Barbro Persson, Oskar Eriksson, Anna M. Blom, Karin Fromell, Michael Hultström, Markus Huber-Lang, Kristina N. Ekdahl, Robert Frithiof, Bo Nilsson
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.627579/full
_version_ 1819169444439523328
author Miklós Lipcsey
Miklós Lipcsey
Barbro Persson
Oskar Eriksson
Anna M. Blom
Karin Fromell
Michael Hultström
Michael Hultström
Markus Huber-Lang
Kristina N. Ekdahl
Kristina N. Ekdahl
Robert Frithiof
Bo Nilsson
author_facet Miklós Lipcsey
Miklós Lipcsey
Barbro Persson
Oskar Eriksson
Anna M. Blom
Karin Fromell
Michael Hultström
Michael Hultström
Markus Huber-Lang
Kristina N. Ekdahl
Kristina N. Ekdahl
Robert Frithiof
Bo Nilsson
author_sort Miklós Lipcsey
collection DOAJ
description An important manifestation of severe COVID-19 is the ARDS-like lung injury that is associated with vascular endothelialitis, thrombosis, and angiogenesis. The intravascular innate immune system (IIIS), including the complement, contact, coagulation, and fibrinolysis systems, which is crucial for recognizing and eliminating microorganisms and debris in the body, is likely to be involved in the pathogenesis of COVID-19 ARDS. Biomarkers for IIIS activation were studied in the first 66 patients with COVID-19 admitted to the ICU in Uppsala University Hospital, both cross-sectionally on day 1 and in 19 patients longitudinally for up to a month, in a prospective study. IIIS analyses were compared with biochemical parameters and clinical outcome and survival. Blood cascade systems activation leading to an overreactive conjunct thromboinflammation was demonstrated, reflected in consumption of individual cascade system components, e.g., FXII, prekallikrein, and high molecular weight kininogen and in increased levels of activation products, e.g., C4d, C3a, C3d,g, sC5b-9, TAT, and D-dimer. Strong associations were found between the blood cascade systems and organ damage, illness severity scores, and survival. We show that critically ill COVID-19 patients display a conjunct activation of the IIIS that is linked to organ damage of the lung, heart, kidneys, and death. We present evidence that the complement and in particular the kallikrein/kinin system is strongly activated and that both systems are prognostic markers of the outcome of the patients suggesting their role in driving the inflammation. Already licensed kallikrein/kinin inhibitors are potential drugs for treatment of critically ill patients with COVID-19.
first_indexed 2024-12-22T19:19:36Z
format Article
id doaj.art-88e2b39188194cf78855a73bdfa67f99
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-22T19:19:36Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-88e2b39188194cf78855a73bdfa67f992022-12-21T18:15:25ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-02-011210.3389/fimmu.2021.627579627579The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin SystemMiklós Lipcsey0Miklós Lipcsey1Barbro Persson2Oskar Eriksson3Anna M. Blom4Karin Fromell5Michael Hultström6Michael Hultström7Markus Huber-Lang8Kristina N. Ekdahl9Kristina N. Ekdahl10Robert Frithiof11Bo Nilsson12Department of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, SwedenHedenstierna Laboratory, Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, SwedenDepartment of Immunology Genetics and Pathology, Uppsala University, Uppsala, SwedenDepartment of Immunology Genetics and Pathology, Uppsala University, Uppsala, SwedenDepartment of Translational Medicine, Lund University, Malmö, SwedenDepartment of Immunology Genetics and Pathology, Uppsala University, Uppsala, SwedenDepartment of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, SwedenUnit for Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, SwedenInstitute for Clinical and Experimental Trauma-Immunology, University Hospital of Ulm, Ulm, GermanyDepartment of Immunology Genetics and Pathology, Uppsala University, Uppsala, SwedenLinnaeus Centre for Biomaterials Chemistry, Linnaeus University, Kalmar, SwedenDepartment of Surgical Sciences, Anesthesiology and Intensive Care, Uppsala University, Uppsala, SwedenDepartment of Immunology Genetics and Pathology, Uppsala University, Uppsala, SwedenAn important manifestation of severe COVID-19 is the ARDS-like lung injury that is associated with vascular endothelialitis, thrombosis, and angiogenesis. The intravascular innate immune system (IIIS), including the complement, contact, coagulation, and fibrinolysis systems, which is crucial for recognizing and eliminating microorganisms and debris in the body, is likely to be involved in the pathogenesis of COVID-19 ARDS. Biomarkers for IIIS activation were studied in the first 66 patients with COVID-19 admitted to the ICU in Uppsala University Hospital, both cross-sectionally on day 1 and in 19 patients longitudinally for up to a month, in a prospective study. IIIS analyses were compared with biochemical parameters and clinical outcome and survival. Blood cascade systems activation leading to an overreactive conjunct thromboinflammation was demonstrated, reflected in consumption of individual cascade system components, e.g., FXII, prekallikrein, and high molecular weight kininogen and in increased levels of activation products, e.g., C4d, C3a, C3d,g, sC5b-9, TAT, and D-dimer. Strong associations were found between the blood cascade systems and organ damage, illness severity scores, and survival. We show that critically ill COVID-19 patients display a conjunct activation of the IIIS that is linked to organ damage of the lung, heart, kidneys, and death. We present evidence that the complement and in particular the kallikrein/kinin system is strongly activated and that both systems are prognostic markers of the outcome of the patients suggesting their role in driving the inflammation. Already licensed kallikrein/kinin inhibitors are potential drugs for treatment of critically ill patients with COVID-19.https://www.frontiersin.org/articles/10.3389/fimmu.2021.627579/fullthromboinflammationkallikrein/kinin systemcomplement systemcoagulation systemfibrinolysis systemCOVID-19
spellingShingle Miklós Lipcsey
Miklós Lipcsey
Barbro Persson
Oskar Eriksson
Anna M. Blom
Karin Fromell
Michael Hultström
Michael Hultström
Markus Huber-Lang
Kristina N. Ekdahl
Kristina N. Ekdahl
Robert Frithiof
Bo Nilsson
The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
Frontiers in Immunology
thromboinflammation
kallikrein/kinin system
complement system
coagulation system
fibrinolysis system
COVID-19
title The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
title_full The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
title_fullStr The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
title_full_unstemmed The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
title_short The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
title_sort outcome of critically ill covid 19 patients is linked to thromboinflammation dominated by the kallikrein kinin system
topic thromboinflammation
kallikrein/kinin system
complement system
coagulation system
fibrinolysis system
COVID-19
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.627579/full
work_keys_str_mv AT mikloslipcsey theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT mikloslipcsey theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT barbropersson theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT oskareriksson theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT annamblom theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT karinfromell theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT michaelhultstrom theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT michaelhultstrom theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT markushuberlang theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT kristinanekdahl theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT kristinanekdahl theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT robertfrithiof theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT bonilsson theoutcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT mikloslipcsey outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT mikloslipcsey outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT barbropersson outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT oskareriksson outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT annamblom outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT karinfromell outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT michaelhultstrom outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT michaelhultstrom outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT markushuberlang outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT kristinanekdahl outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT kristinanekdahl outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT robertfrithiof outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem
AT bonilsson outcomeofcriticallyillcovid19patientsislinkedtothromboinflammationdominatedbythekallikreinkininsystem